Key facts
- This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 20 Nov 2023, 17:31.
Pascal Touchon - 16 Nov 2023 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)
- Signature
- /s/ Jeff Kiekhofer, Attorney-in-Fact for Pascal Touchon
- Issuer symbol
- ATRA
- Transactions as of
- 16 Nov 2023
- Net transactions value
- -$7,939
- Form type
- 4
- Filing time
- 20 Nov 2023, 17:31:30 UTC
- Previous filing
- 18 Aug 2023
- Next filing
- 09 Jan 2024
- SEC
- View on sec.gov
Key filing fact
Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 20 Nov 2023.
Change
- Previous filing in this sequence was filed on 18 Aug 2023.
- Current net transaction value: -$7,939.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
ATRA
transaction
Common Stock
Sale
- Transaction value
- $7,939
- Shares
- -20,409
- Change %
- -3%
- Price
- $0.3890
- Shares after
- 655,496
- Date
- 16 Nov 2023
- Ownership
- Direct
- Footnotes
- F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement. |
| F2 | The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee. |